Cathelijne Frielink - Concepedia

Concepedia

Author

Cathelijne Frielink

Radboud University Nijmegen

Also Known As

C Frielink, C. Frielink, Cathelijne Frielink

74

Publications

2.2K

Citations

22

H-Index

64

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Center for Molecular Medicine and Immunology Immunomedics (United States)University Medical Center

CF

About

Cathelijne Frielink is an author at Radboud University Nijmegen specializing in medicine, engineering, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.2K
2	Engineering	7	7	632
3	Biomedical Engineering	2	2	81
4	Health Sciences	1	1	37
5	Natural Sciences	1	1	140

Cathelijne Frielink

×

38

Publications

2.2K

Citations

22

H-Index

	Year	Citations
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. Marcel L Janssen, Wim J.G. Oyen, Ingrid Dijkgraaf, PubMed EngineeringCancer BiologyTumor BiologyNude Mouse ModelSmall Peptides	2002	331
Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity M.H.M.G.M. den Brok, Roger P.M. Sutmuller, Stefan Nierkens, British Journal of Cancer	2006	283
Biological correlates of FDG uptake in non-small cell lung cancer Lioe‐Fee de Geus‐Oei, J. Han van Krieken, Riena P. Aliredjo, Lung Cancer OncologyOncologic ImagingMedicinePathologyBiological Correlates	2007	200
Comparison of a Monomeric and Dimeric Radiolabeled RGD-Peptide for Tumor Targeting Marcel Janssen, Wim J.G. Oyen, Leon F.A.G. Massuger, Cancer Biotherapy and Radiopharmaceuticals EngineeringPeptide EngineeringTumor BiologyOncologyRadiopharmaceutical Therapy	2002	172
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re. Adrienne H. Brouwers, Julliëtte E M van Eerd, Cathelijne Frielink, PubMed	2004	141
Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin Maarten Brom, Wietske Woliner-van der Weg, Lieke Joosten, Diabetologia Beta Cell MassMedicineNatural SciencesBioanalysisMass Spectrometry	2014	140
α<sub>v</sub>β<sub>3</sub> Integrin‐targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide Ingrid Dijkgraaf, John A. W. Kruijtzer, Cathelijne Frielink, International Journal of Cancer PathologyPeptide ScienceTumor UptakeTumor BiologyOvarian Cancer	2006	65
Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody Catharina M. van Rij, Susanne Lütje, Cathelijne Frielink, European Journal of Nuclear Medicine and Molecular Imaging UrologyGenitourinary CancerMedicineProstatic DiseaseImmunotherapy	2013	53
Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors Susanne Lütje, Sandra Heskamp, Gerben M. Franssen, Theranostics	2019	50
Improved Tumor Targeting of Radiolabeled RGD Peptides Using Rapid Dose Fractionation Marcel Janssen, Cathelijne Frielink, Ingrid Dijkgraaf, Cancer Biotherapy and Radiopharmaceuticals	2004	46

Page 1